Calling the Situation Grim, the Supreme Court Takes Suo Motu Cognizance of Delays in NCLT Approvals  ||  Supreme Court: Admission of a Claim by a Resolution Professional is Not Debt Acknowledgment  ||  Supreme Court: Public Figures Must Exercise Caution as Their Words Have Consequences in Society  ||  SC: State Must Act as a Model Employer, Criticising the Union For Not Regularising ISRO Workers  ||  J&K&L High Court: Minor Minerals Have Major Environmental Impacts and Must be Regulated  ||  Del HC: Unexplained Money Received by Public Servant is Not Bribery Without Proof of Official Favour  ||  Del HC: There is No Absolute Bar on Granting Co-Convicts Parole/Furlough Together in Suitable Cases  ||  Bom HC: LARR Authority Can Examine Limitation Issues in Land Acquisition References under 2013 Act  ||  MP HC: Long-Serving Employees Cannot Be Denied Regularisation by Retrospective Statutory Amendments  ||  J&K&L HC: Routine Challenges to Lok Adalat Awards Defeat Their Purpose of Quick Dispute Resolution    

Central Government permitted M/s. Cipla Limited to import morphine, codeine, the baine and their salts after following the procedure specified in NDPS Rules- (Ministry of Finance ) (27 Aug 2020)

MANU/REVU/0064/2020

Law of Medicine

1. In exercise of the powers conferred by the proviso to rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985, the Central Government hereby notifies that M/s. Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadma Marg, Lower Parel, Mumbai-400013, is permitted to import morphine, codeine, thebaine and their salts for use in manufacture of products to be exported, after following the procedure specified in Rule 55 of the said rules and subject to such conditions as may be specified in the import certificate issued in Form No. 4A annexed to the aforesaid rules.

2. This notification shall remain in force from the date of its publication in the Official Gazette till the 31st day of December, 2022.

Tags : CIPLA LIMITED   PERMISSION   IMPORT  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved